Skip to main content
Premium Trial:

Request an Annual Quote

Roche to Distribute Aclara s Arteas LabCards

NEW YORK, Nov. 7 – Aclara BioSciences said Wednesday that Roche Applied Science had agreed to market its Arteas LabCard product, which is designed to allow researchers to run assays using small amounts of consumables. 

Roche Applied Science, a business unit of Roche Diagnostics, will begin launching the Arteas product in the first quarter of next year. Until then, Aclara will continue selling its LabCards. 

Roche has also obtained rights to negotiate to market additional Aclara products.

"After a thorough evaluation, we concluded that ACLARA possessed an unusual combination of strengths in both microfluidics and application chemistries, which together solve important customer needs,” Juergen Flach, general manager of Roche Diagnostics Corporation, said in a statement. 

Aclara said that LabCard require 10 – 100 times less consumables than conventional microwell plates.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.